mesalamine has been researched along with Scleroderma, Localized in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Scleroderma, Localized: A term used to describe a variety of localized asymmetrical SKIN thickening that is similar to those of SYSTEMIC SCLERODERMA but without the disease features in the multiple internal organs and BLOOD VESSELS. Lesions may be characterized as patches or plaques (morphea), bands (linear), or nodules.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Veligotskiĭ, NN | 1 |
| Parkhomenko, LK | 1 |
| Simeunovich, S | 1 |
| Skopichenko, SV | 1 |
1 other study available for mesalamine and Scleroderma, Localized
| Article | Year |
|---|---|
[Combined surgical and therapeutic treatment of complicated ulcerative necrotic enterocolitis on the background of scleroderma using Salofalk preparation].
Topics: Abdomen, Acute; Abdominal Injuries; Adolescent; Aminosalicylic Acids; Anti-Inflammatory Agents, Non- | 1994 |